Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • No direct link found between rising inequality, reduced trust

  • Diversity in developmental trajectories in kids with autism spectrum disorder

  • Common elements of STEM schools identified

  • Financial incentives help pregnant women to quit smoking

  • Grant to develop therapy to protect against nerve agents

  • Up to 2 per cent of Germany's population is dependent on hypnotics

  • Low-frequency deep brain stimulation improves difficult-to-treat Parkinson's symptoms

  • Sexual offending treatment programs in prisons, hospitals are ineffective

  • Fluorescent dyes 'light up' brain cancer cells

  • Stress shared by same-sex couples can have unique health impacts

  •